Successful Treatment of Hip Involvement in SAPHO Syndrome with Baricitinib

Overview

Journal Rheumatol Adv Pract

Publisher Oxford University Press

Specialty Rheumatology

Date 2022 Nov 16

PMID 36382263

Authors

Wuriliga

Xia Wu

Yihan Cao

Chen Li

Affiliations

Soon will be listed here.

Citing Articles

What Is New and What Is Next for SAPHO Syndrome Management: A Narrative Review.

Ferraioli M, Levani J, De Luca R, Matucci-Cerinic C, Gattorno M, Guiducci S J Clin Med. 2025; 14(4).

PMID: 40004896 PMC: 11856149. DOI: 10.3390/jcm14041366.

Is palmoplantar pustulosis combined with hip involvement a SAPHO syndrome?.

Sun Q, Meng F, Chen N, Li C, Ying Z Postepy Dermatol Alergol. 2024; 41(3):328-330.

PMID: 39027691 PMC: 11253312. DOI: 10.5114/ada.2024.141097.

Update on ocular manifestations of the main monogenic and polygenic autoinflammatory diseases.

Fonollosa A, Carreno E, Vitale A, Jindal A, Ramanan A, Pelegrin L Front Ophthalmol (Lausanne). 2024; 4:1337329.

PMID: 38984133 PMC: 11182141. DOI: 10.3389/fopht.2024.1337329.

Successful Treatment of Refractory Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome with Baricitinib, a Janus Kinase Inhibitor.

Yang J, Yuan C, Zhou S, Teng Z, Li M Clin Cosmet Investig Dermatol. 2024; 17:529-537.

PMID: 38463557 PMC: 10921886. DOI: 10.2147/CCID.S446468.

References

Yeo I, Cha H, Yoon Y, Park Y, Lim S . A case report of severely damaged hip joint caused by SAPHO syndrome treated with 2-stage total hip arthroplasty. Medicine (Baltimore). 2016; 95(27):e4168. PMC: 5058867. DOI: 10.1097/MD.0000000000004168. View

Li Y, Huo J, Cao Y, Yu M, Zhang Y, Li Z . Efficacy of tofacitinib in synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: a pilot study with clinical and MRI evaluation. Ann Rheum Dis. 2020; 79(9):1255-1257. DOI: 10.1136/annrheumdis-2020-217250. View